CA Patent

CA2995798A1 — Liquid formulations containing picosulfate and magnesium citrate

Assigned to Ferring BV · Expires 2017-02-23 · 9y expired

What this patent protects

Liquid formulations containing picosulfate and magnesium citrate are provided. The formulations are useful to treat constipation or for the clearance of the bowel prior to X-ray examination, endoscopy or surgery.

USPTO Abstract

Liquid formulations containing picosulfate and magnesium citrate are provided. The formulations are useful to treat constipation or for the clearance of the bowel prior to X-ray examination, endoscopy or surgery.

Drugs covered by this patent

Patent Metadata

Patent number
CA2995798A1
Jurisdiction
CA
Classification
—
Expires
2017-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Ferring BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.